The research in mouse models of breast cancer indicates that COL1A1 is a key extracellular matrix gene and is identified with copy number alterations through integrative in vitro and in vivo studies (59), while COL1A2 methylation is associated with ER/PR receptor status in breast cancer cohort (60). This evidence concerns the gene COL1A1 and breast cancer.